Skip to main content
SpringerLink
Log in

Adalimumab

Demyelinating disorder: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bellesi M, Logullo F, Di Bella P, Provinciali L.CNS demyelination during anti-tumor necrosis factor alpha therapy. Journal of Neurology 253: 668-669, No. 5, May 2006 - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab. React. Wkly. 1112, 6 (2006). https://doi.org/10.2165/00128415-200611120-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611120-00015

Keywords

Search

Navigation